restrictive fluid administration

Restrictive fluid administration, in the context of the Tel-Aviv Sourasky Medical Center study, refers to a specific intraoperative fluid management protocol using Ringer's Lactate (RL) solution for patients undergoing video-assisted thoracic surgery (VATS) for lung resection. This regimen involves the intravenous administration of RL at a restricted rate of 2 ml/kg/hr throughout the surgery, contrasting with standard or liberal regimens that typically use higher volumes (e.g., 8 ml/kg/hr). The primary therapeutic goal of this restrictive approach is to maintain adequate systemic perfusion while minimizing the risk of fluid overload, which can lead to postoperative pulmonary complications such as acute lung injury (ALI) and pulmonary edema. By limiting the volume of crystalloids administered, the protocol aims to improve postoperative outcomes, including reduced morbidity, mortality, and shorter hospital stays for patients with lung diseases requiring surgical intervention.

Other names

restrictive fluid administration-Tel-Aviv Sourasky Medical Center-lung diseases requiring surgeryintraoperative fluid restrictionrestrictive fluid regimenrestrictive Ringer's lactate administration